Zdrowie i gospodarka · 01/08/1997

FDA Reopens Comment Period for Proposed Data Collection on OTC Drug Labels

The Food and Drug Administration (FDA) is extending the public comment period for a proposed data collection effort on consumer preferences and comprehension of different formats and methods for communication in over-the-counter (OTC) drug labels, as required by the Paperwork Reduction Act of 1995.